PROK

Biotech

ProKidney Corp. Skyrockets 515% on Trial Data, But is it a Buy?

Shares of ProKidney Corp. (NASDAQ: PROK) soared 515% on Tuesday, triggering shockwaves across Wall Street after the…

Back to top button